Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 4/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.55 |
| ▸ | MAOB | P27338 | 3/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16440936 | 0.94 | FFAR1 (0.54) | APPHRH3MAOBLTA4HEPHX2 | |
| SCHEMBL16428800 | 0.94 | FFAR1 (0.54) | APPHRH3MAOBLTA4HEPHX2 | |
| SCHEMBL13845303 | 0.92 | APP (0.61) | APPHRH3LTA4HEPHX2FFAR1 | |
| SCHEMBL19864469 | 0.92 | MAOB (0.57) | APPHRH3MAOBFFAR1SENP8 | |
| SCHEMBL10784840 | 0.92 | LTA4H (0.64) | HRH3MAOBLTA4HEPHX2FFAR1 | |
| SCHEMBL13845318 | 0.90 | APP (0.62) | APPHRH3MAOBFFAR1 | |
| SCHEMBL8039313 | 0.90 | MAOB (0.62) | APPHRH3MAOB | |
| SCHEMBL16440939 | 0.90 | MAOB (0.67) | APPHRH3MAOBSENP8SENP7 | |
| SCHEMBL15196499 | 0.90 | FFAR1 (0.61) | APPMAOBLTA4HEPHX2FFAR1 | |
| Fluoride SCHEMBL9841526 | 0.89 | HRH3 (0.48) | APPHRH3MAOBLTA4HEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9957213-B2 | Organic compound, liquid crystal composition, liquid crystal element, and liquid crystal display device | SEMICONDUCTOR ENERGY LABORATORY CO. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9957213-B2 | Organic compound, liquid crystal composition, liquid crystal element, and liquid crystal display device | SEMICONDUCTOR ENERGY LABORATORY CO. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20150034870-A1 | ORGANIC COMPOUND, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-02-05 | — | — | US | disclosed |
| US-20150034870-A1 | ORGANIC COMPOUND, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150034870-A1 | ORGANIC COMPOUND, LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL DISPLAY DEVICE | AR, OCIAD1, RCC2 | APP 871/4885HRH3 415/4885MAOB 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.